Carpal tunnel syndrome. Mononeuropathies of upper limb,Carpal tunnel syndrome
Conditions
Interventions
Intervention 1: The second group wear wrist splint(product of Iran Odor company) for 8 weeks during nights. Intervention 2: The first group receive 40 mg triamcinolone Acetonide(Triamhexal 40,1 mg
Treatment - Devices
Treatment - Drugs
The second group wear wrist splint(product of Iran Odor company) for 8 weeks during nights.
The first group receive 40 mg triamcinolone Acetonide(Triamhexal 40,1 mg crystalline suspension,intraarticular,manufactured of Holzkirchen factory in Germany)in involved wrist of severe CTS.
Sponsors
Vice chancellor for research,Yasuj University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
15 Years to 49 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria includes women that had paresthesia of hands during pregnancy(pregnancy related carpal tunnel syndrome) and ages between 15 and 49 y/o). Exclusion criteria in this study are diabetes mellitus, collagen vascular disease, renal failure, hypothyroidism, rheumatoid disease, pre-pregnancy carpal tunnel syndrome, positive family history of neuropathy, carpal tunnel surgery and fracture of wrist bones.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of pregnancy related CTS. Timepoint: In start of study and 2 months after intervention. Method of measurement: Clinical examination and electrodiagnostic studies. | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain and numbness of fingers. Timepoint: Before and 2 months after treatment intervention. Method of measurement: Visual analogue scale and electrodiagnostic studies. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHosin Rahimipour
Yasuj University of Medical Sciences
Outcome results
None listed